I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the exciting collaboration between two leaders in laboratory
In the rapidly evolving landscape of cancer treatment, few innovations have captured as much attention as chimeric antigen receptor T cell (CAR-T) therapy, a groundbreaking method that reprograms a patient’s immune cells to attack cancer with remarkable precision. Originally developed as a niche
Imagine a world where menstrual products not only manage a natural bodily function but also safeguard health, protect the environment, and empower millions of women globally by breaking down barriers of access and stigma. For too long, menstrual health has been an underfunded and overlooked field,
What happens when the tools used to fight one of the deadliest cancers fail to tell the full story, and how can a new approach change the game? Glioblastoma, an aggressive brain cancer with a survival rate of less than 15 months for most patients, has long evaded effective treatment, but a
Imagine a world where life-saving medical research grinds to a halt, not because of a lack of expertise or innovation, but due to political disputes far removed from the lab. This scenario is unfolding across the University of California (UC) system, where federal funding freezes initiated by the
Imagine a world where a cancer diagnosis doesn't come with the added burden of financial ruin, where access to life-saving treatment depends not on income or zip code but on need alone, and where policies like Medicaid expansion bring this vision closer to reality. This cornerstone of healthcare
